Showing posts with label Long Regeneron. Show all posts
Showing posts with label Long Regeneron. Show all posts

Monday, January 30, 2012

Regeneron : Great portfolio of molecules

Regeneron has one of the best pipeline of new molecules. Despite the criticism the author believes there is significant upside.

The author has purchased Regeneron (REGN) at $88.24.